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Abstract The aortic valve was long considered a passive structure that opens and closes in
response to changes in transvalvular pressure. Recent evidence suggests that the aortic valve per-
forms highly sophisticated functions as a result of its unique microscopic structure. These functions
allow it to adapt to its hemodynamic and mechanical environment. Understanding the cellular and
molecular mechanisms involved in normal valve physiology is essential to elucidate the mechanisms
behind valve disease. We here review the structure and developmental biology of aortic valves; we
examine the role of its cellular parts in regulating its function and describe potential pathophysio-
logical and clinical implications.
ª 2009 University of Cairo. All rights reserved.
Introduction
The aortic valve lies at the junction between the left ventricle and
the aorta. It opens and closes >100.000 times daily. For a long
time, the aortic valve was believed to be a passive structure that
opens and closes in response to changes in transvalvular pres-
sures. Although this is partly true, recent evidence clearly dem-
onstrates that the aortic valve has a tightly regulated and highly
conserved architecture which allows it to perform sophisticated
functions, in turn affecting systolic blood ﬂow, ventricular
workload and coronary blood ﬂow, among other things. In
addition, the cellular components of the valve play an important
role in maintaining normal valve architecture and composition.
Dysregulation in one of the elements can lead to dysfunction
and dysmorphic changes of the valve. In this review, we will dis-
cuss the unique structure of the aortic valve. We will then focus
on the role of aortic valve endothelial cells in maintaining valve
structure and function and their possible role in calciﬁed aortic
valve disease, with an emphasis on clinical implications.
Aortic valve structure
Macroscopic structure
The aortic valve mechanism is composed of four inter-related
component parts which form a functional unit: the aortic
annulus, the aortic cusps, the sinuses of Valsalva and the sin-
otubular junction. The normal aortic valve is composed of
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three semi-lunar cusps that are attached to a crown-shaped
annulus at their base. Adequate and coordinated opening of
the aortic valve is essential to ensure unobstructed laminar
blood ﬂow from the left ventricle and decrease ventricular
workload in systole [1–4]. Similarly, proper closure of the
cusps in diastole preserves the shape of the root and contrib-
utes to the creation of vortices in the sinuses of Valsalva, an
important determinant of adequate coronary blood ﬂow in
diastole and in systole [5,6]. The aortic valve lies in a unique
hemodynamic and mechanical environment exposing the cusps
to a wide range of stresses during the cardiac cycle, which
range from pressure, to tension and bending forces. Although
aortic valve cusps are extremely thin structures, yet both sides
of the valve are exposed to different stresses, in particular
shear stress which is a major stimulus for valve endothelial
cells (VECs). The ventricular side of the cusps is exposed to
high-shear stress due to a systolic, high velocity, laminar blood
ﬂow, whereas the aortic side of the cusps is exposed to low-
shear stress secondary to diastolic, low velocity, disturbed
blood ﬂow. VECs have the ability to sense changes in shear
stress and to translate these mechanical stimuli into biological
responses (mechanotransduction) [7]. Previous studies focusing
on the vascular endothelium show that different patterns of
ﬂow can greatly inﬂuence the response of underlying tissues
through activation of speciﬁc mechanotransduction pathways
in the endothelium, which can lead to structural changes at
the level of the vessel wall.
Cellular structure
In addition to the VECs which line both sides of the cusp, the
body of the aortic valve is composed of valve interstitial cells
(VICs) lying within the extracellular matrix (ECM) (Fig. 1).
VICs are composed of different cell types, namely ﬁbroblasts,
smooth muscle cells and myoﬁbroblasts [8]. Smooth muscle
cells can exhibit both secretory and contractile properties.
Along with the ﬁbroblasts, these secretory properties are
responsible for generation, maintenance and repair of the
ECM which is mainly composed of elastin, collagen and prote-
oglycans [9]. The three-dimensional microscopic architecture of
the aortic valve cusps is highly preserved between species and
consists of three layers distinguishable by their chemical com-
position and mechanical properties [10] (Fig. 1). On the aortic
side lies the ﬁbrosa, a layer rich in collagen ﬁbers which pro-
vides most of the tensile strength to the valve. On the ventricu-
lar side is the ventricularis which is rich in elastin ﬁbers, thus
providing elasticity to the aortic valve. Between these two layers
is the spongiosa, which represents about 60–70% of the thick-
ness of the cusp and is primarily composed of proteoglycans.
Proteoglycans are highly hydrated, thus acting as ‘‘shock
absorbers’’ during the different parts of the cardiac cycle.
In addition to this basic structure of aortic valves, a popu-
lation of resident stem cells lying within the cusps has recently
been recognized [11]. They appear to originate from the mobi-
lization of hematopoietic-derived stem cells towards cardiac
valves [12]. Their role is not yet fully understood but they
are thought to contribute to valve repair, cell regeneration,
as well as participating in valve calciﬁcation in some disease
states as will be discussed later. Although aortic valves are
avascular structures which extract their nutrients by extraction
from surrounding blood, they are richly innervated by a highly
preserved network of afferent and efferent nerves which con-
tribute to valve structure and function [13–15].
Cell lineage and developmental biology
Aortic valve originate from endocardial cushions in the devel-
oping embryo. Endocardial cushions result from the migration
of endothelial cells into the cardiac jelly, followed by a process
of endothelial-to-mesenchymal transformation (EMT) which
initiates what will eventually become a tri-layered aortic valve
structure. Migration, differentiation and delamination of these
cells is a tightly controlled series of processes which depend on
the activity of speciﬁc signaling molecules such as NOTCH1,
transforming growth factor b (TGF-b) and the wnt/b-catenin
pathway [16–19], as well hemodynamic cues [20]. Importantly,
the embryonic outﬂow tract which would ultimately yield the
aortic and pulmonary valves as well as the ascending aorta
and pulmonary artery are composed of cells derived from
the neural crest [21]. NOTCH1 is also involved in regulating
the migration and differentiation of these cells in the embryo
[17]. Understanding the developmental biology of the aortic
valve and root has important implications for understanding
normal and diseased valve physiology because most of the sig-
nals that are operational during morphogenesis continue to
inﬂuence growth and adaptation in postnatal life [22]. For in-
stance, EMT continues into adult life as demonstrated by the
differentiation of mature VECs into mesenchymal cells
expressing smooth muscle a-actin, a process which could con-
tribute to valve repair and interstitial cell regeneration [23]. In
addition, deﬁning cell lineages helps explain differences in cell
behaviour in response to common stimuli [24].
Aortic valves lie in a unique hemodynamic environment
Blood ﬂowing through the vasculature generates shear stress
on the luminal side of the vessel, which is entirely lined by
endothelium. Shear stress represents the frictional force per
unit area. The magnitude of shear stress can be estimated in
most of the vasculature by Poiseuille’s law stating that wall
shear stress is proportional to blood ﬂow viscosity and volu-
Figure 1 Histological section showing the triple layer architec-
ture of a normal aortic valve. Endothelial cells form a monolayer
on each side of the cusp. Interstitial cells, a mix of ﬁbroblasts,
smooth muscle cells (SMCs) and myoﬁbroblasts ﬁll the body of
the cusp. They possess contractile and secretory properties and are
responsible for the synthesis and repair of the surrounding
extracellular matrix.
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metric ﬂow rate and inversely proportional to the third power
of the internal radius [25]. While actual wall shear stress is very
difﬁcult to estimate, mean shear stress along an artery is esti-
mated at 20 dynes/cm2. Unlike blood vessels, the aortic valve
is not a cylindrical structure, therefore estimation of shear
stress levels on either side of the valve requires more complex
modelling. Nevertheless, the pattern of ﬂow on the aortic and
the ventricular sides of the valve has been recognized for a long
time. Leonardo da Vinci was the ﬁrst to accurately describe the
laminar ﬂow on the ventricular surface of the valve and the dis-
turbed vortex ﬂow in the sinuses of Valsalva to which ECs on
the aortic side are exposed. Estimates of actual valve shear
stresses have varied signiﬁcantly in the literature [26–30]. Some
have suggested that mean shear stress along the ventricular
surface of the aortic valve is around 20 dynes/cm2 [30,31],
while others estimate actual peak shear stress on the ventricu-
lar surface at 80 dynes/cm2 whereas it oscillates between +10
and 8 dynes/cm2 on the aortic surface [32]. Flow along the
ventricular surface is a high-shear laminar ﬂow whereas it is
a low-shear disturbed ﬂow on the aortic side.
Endothelial cell heterogeneity
The endothelium is a monolayer of cells lining blood and lym-
phatic vessels which sits at the interface between all body or-
gans and blood. They possess anti-thrombogenic, anti-
adhesive, anti-proliferative and vasodilatory properties which
mainly result from the synthesis and release of nitric oxide
(NO), its major biosynthetic product and prostacyclin
(PGI2). Nevertheless, although all endothelial cells throughout
the body share the same basic properties, studies have demon-
strated a considerable amount of heterogeneity between the
endothelium from different regions of the body both at the
structural and functional levels [33]. Structurally, although
most endothelial cells have a typical cobblestone appearance,
they can vary signiﬁcantly in thickness, ranging from 0.1 lm
in capillaries and veins to 1 lm in the aorta. In addition, the
number, distribution and properties of tight and adherens
junctions between them varies signiﬁcantly from one vascular
bed to another reﬂecting endothelial adaptation to its hemody-
namic and metabolic environment. Junctions are tighter in
large vessels exposed to high-shear stresses and ﬂow rates than
small arterioles, capillaries or venules. Finally, the endothe-
lium can be continuous (large arteries and veins) or discontin-
uous (liver sinusoidals), fenestrated or non-fenestrated to allow
ﬁltration and transendothelial transport. Similarly, endothelial
cells exhibit marked functional heterogeneity on several levels:
permeability, mechanotransduction pathways in response to
mechanical stimuli and angiogenesis among other functions.
Aortic valve endothelial cells exhibit unique properties
Mechanotransduction and alignment
For a long time, aortic VECs were thought to play a minor
role in valve physiology because valves were considered passive
structures that opened and closed in response to changes in
transvalvular pressure. More recently, several studies focusing
on the structural and functional properties of aortic VECs sug-
gest that valvular endothelium possesses unique properties
which distinguish it from other endothelial beds, particularly
the endothelium lining the aorta with which it lies in direct
continuity. The most striking difference between valvular
and vascular endothelial cells is cell alignment with regards
to ﬂow orientation. Whereas the vascular endothelium
throughout the body aligns with the long axis of the cell par-
allel to ﬂow [34] (except in areas of turbulent ﬂow) [35], VECs
are aligned perpendicular to the direction of ﬂow [31,36]
(Fig. 2). This was ﬁrst described by Deck [36] by electron
microscopic analysis of explanted aortic valves and further val-
idated by in vitro studies [31]. Cultured porcine aortic VECs
were compared to aortic (vascular) endothelial cells from the
same animal in response to unidirectional non-pulsatile lami-
nar ﬂow at 20 dynes/cm2. Whereas vascular cells were aligned
parallel to ﬂow after 24 h, instead, VECs aligned perpendicular
to ﬂow even without the presence of an aligned substrate [37].
These adaptations were dependent on cytoskeletal reorienta-
tion, a process involving different mechanotransduction path-
ways in each type of endothelium. Laminar ﬂow induced
activation of Rho-kinase, phosphatidylinositol-3-kinase and
Figure 2 (a) Scanning electron microscopy of aortic valve
endothelial cells forming a monolayer on the surface of the aortic
cusps (1000·). The cells are tightly joined and aligned thus
constituting the link between the blood milieu and the interstitial
space. (b) Scanning electron microscopy of aortic valve endothelial
cells on the aortic side of the cusp at higher magniﬁcation (5000·).
Microcilia on the surface of the cells are visible and likely act as
sensors of changes in hemodynamic shear stress, in turn activating
different intracellular mechanotransduction pathways.
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calpain pathways in vascular endothelial cells, whereas VECs
did not require activation of the latter for cytoskeletal reorga-
nization [31].
Gene expression proﬁle
VECs also appear to have a higher proliferation rate than vas-
cular endothelial cells [38]. Furthermore, both sets of cells pos-
sess different transcription proﬁles. In a study examining the
transcription proﬁles of 847 genes, there was common expres-
sion of 55 activated genes whereas a further 48 genes were dif-
ferentially activated. Among those genes with a higher
activation in the valvular ECs were transcription factors
associated with higher proliferation rate such as jun D and
protein kinase C [38]. Notably, both vascular endothelium
and VECs expressed markers linked with calciﬁcation such
as osteonectin, bone morphogenic protein-7 and -9 (BMP-7
and BMP-9). Differences in gene expression proﬁle between
vascular and valvular endothelium were further validated by
another study showing different gene expression proﬁles in re-
sponse to shear stress stimulation of cultured porcine aortic
endothelial cells or VECs [37]. In that study, Butcher et al.
showed preferential expression of genes associated with chon-
drogenesis by VECs whereas vascular endothelial cells ex-
pressed more genes associated with osteogenesis. Shear stress
reduced the expression of osteogenic genes [37].
Aortic valve endothelial cells are different on both sides of the
valve
Aortic valve calciﬁcation is a major clinical problem in elderly
patients and those with bicuspid aortic valve disease. With in-
creased life expectancy, improved diagnostic techniques and
better global access to health care, the incidence of aortic valve
calciﬁcation is expected to triple within the next 40 years [39],
making it one of the major sources of cardiovascular disease.
In recent years, it has become increasingly clear that aortic
valve calciﬁcation is an active cell-driven process that shares
many similarities with atherosclerosis. Among those, early
endothelial dysfunction has been shown to act as an initial
occurrence in the cascade of events leading to valve calciﬁca-
tion [40]. Histologically, aortic valve calciﬁcation occurs exclu-
sively on the aortic side of the valve suggesting that perhaps
VECs on the aortic side are less resistant to calciﬁcation than
those on the ventricular side (Fig. 3). Simmons et al. developed
an innovative technique to separately analyze gene expression
of VECs from either side of the valve [41]. This modiﬁed Haut-
chen technique for en face isolation of VECs allowed reliable
extraction of high quality mRNA for analysis of gene expres-
sion proﬁles between both aortic and ventricular VECs. The
authors reported the differential expression of 584 genes
in situ between both sides of the valve [42]. VECs derived from
the aortic side expressed fewer genes associated with inhibition
of calciﬁcation such as oteoprotegerin, parathyroid hormone
and chordin, a protein that inhibits the osteoinductive effects
of BMPs [42]. In addition, aortic-sided VECs showed increased
expression of transcripts linked with bone formation including
BMP4. However, this was balanced by a higher expression of
antioxidative and anti-inﬂammatory genes on the aortic side.
Notably, there were higher levels of endothelial nitric oxide
synthase (eNOS) on the aortic side of the valve. Because the
mRNA obtained in this study originated directly from freshly
explanted aortic valves, it represented a good picture of in situ
gene expression in normal valves. However, the gene array
used was a human array and only covered 12,000 genes. Cur-
rently, porcine gene arrays that cover >24,000 genes are com-
mercially available and could provide additional clues into the
functional side-speciﬁcity of aortic VECs. This will be greatly
enhanced following the full sequencing of the pig genome
which is expected towards the end of 2009. We have recently
succeeded in separately isolating aortic VECs from either side
of the valve and culturing them in vitro. We are currently
studying their intrinsic properties in vitro in an effort to deter-
mine their responses to various mechanical and pharmacolog-
ical stimuli as well as modiﬁcations in gene expression proﬁles.
Differences in ﬂow patterns between both sides of the valve
as described earlier are sensed by a thin layer of glycoproteins
on the luminal surface of endothelial cells called the glycoca-
lyx, which communicates with the cytoskeleton and can
activate several signaling pathways in response to ﬂow
[25,43–45]. This process of translating mechanical stimuli into
biological signals is commonly termed mechanotransduction.
Studies on vascular endothelial cells have demonstrated that
differences in shear stress translate into activation of different
signaling pathways, illustrated by the presence of atheroscle-
rotic plaques in areas of low wall shear stress in the vasculature
such as the carotid artery bifurcation. One of the major acti-
vated signaling pathways is the nuclear factor-kB (NFkB), a
highly conserved transcription factor which translocates to
the nucleus when activated, triggering the production of pro-
inﬂammatory molecules [46,47]. To date, the glycocalyx has
not been identiﬁed or characterized on the surface of aortic
valves. Identiﬁcation of the speciﬁc cell-surface molecules
which contribute to mechanotransduction in VECs could open
new avenues into understanding disease processes in condi-
tions of abnormal shear stresses on the valves.
The different mechanotransduction pathways involved on
either side of the valve in response to different patterns of ﬂow
have yet to be described (Fig. 4). Recently, a ﬂow apparatus
consisting of a cone and plate was developed to allow
in vitro reproduction of aortic and ventricular ﬂow patterns
Figure 3 Histological section of a calciﬁed human aortic valve
from a patient with calciﬁed aortic valve stenosis. Tripp–McKay
silver impregnation staining shows the calcium nodule on the
aortic side of the cusp, below the endothelial layer.
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on aortic valves [32]. Preliminary studies using that system
show that unlike vascular endothelium, VECs on both the aor-
tic and ventricular side were not activated by exposure to bidi-
rectional oscillatory ﬂow (reproducing ﬂow on the aortic side),
as illustrated by an absence of vascular adhesion molecule-1
(VCAM-1), intercellular adhesion molecule-1 (ICAM-1),
E-selectin and BMP4 [48]. However, exposure of aortic-sided
endothelium to high-shear laminar ﬂow (ventricular ﬂow)
resulted in endothelial activation characterized by expression
of these inﬂammatory markers [48]. This underscores the no-
tion that both sets of VECs activate different mechanotrans-
duction pathways in response to similar mechanical stimuli.
Endothelial cells play an important role in normal aortic valve
function
In addition to their traditional role in preserving an anti-adhe-
sive and anti-proliferative surface, VECs are actively involved
in the regulation of aortic valve function. As discussed previ-
ously, mechanical strain on the surface of the cusps as well
as coronary blood ﬂow are both affected by the shape and
stiffness of the aortic valve cusps [5,6,49,50]. Aortic valve cal-
ciﬁcation has been shown to occur in areas of high mechanical
strains on the valve, namely the commissures, the base of the
cusps and the free edges [51]. Changes in the stiffness of the
aortic valve cusps could signiﬁcantly impact stress magnitude
and distribution along the surface of the cusps. We have
recently demonstrated the role of the endothelium in regulat-
ing the mechanical properties of the aortic valve in vitro using
a biaxial micromechanical testing system [52]. In that study,
aortic valve cusps were stimulated with endothelin-1 (ET-1),
a potent vasoconstrictor peptide which is released by endothe-
lial cell or serotonin (5-HT), an agent which mediates the re-
lease of nitric oxide by the endothelium. Addition of ET-1
resulted in a 25% increase in the elastic modulus (stiffness)
of aortic valve cusps, whereas addition of 5-HT induced a
30% decrease in valve stiffness. Interestingly, addition of cyto-
chalasin D, an inhibitor of actin polymerization reversed the
increase in valve stiffness in response to ET-1, highlighting
the role of the contractile elements in the VIC population
and the communication between VECs and VICs in the valve.
These ﬁndings suggest that the aortic valve is capable of
auto-regulation, but that it is also subject to overall systemic
conditions such as hypertension or diabetes which are often
accompanied by dysregulated concentrations of circulating
vasoactive agents. As previously stated, hypertension, smoking
and diabetes are among the risk factors associated with aortic
valve calciﬁcation. In addition to their direct metabolic effects,
this could be secondary to their effect in modulating valve stiff-
ness which could lead to abnormal stress distribution along the
cusps [53].
Is the aortic valve endothelium involved in valve calciﬁcation?
To date, no deﬁnitive link between VECs and valve calciﬁca-
tion has been directly established. Nevertheless, a number of
studies have recently demonstrated a potential causal relation-
ship. Taken together, this cumulative weight of evidence
strongly suggests that the endothelium plays an active role in
the cellular and molecular events involved in aortic valve cal-
ciﬁcation. As mentioned earlier, Simmons et al. showed a dif-
ferent pattern of gene expression between VECs on either side
of the valve characterized by a higher expression of pro-calciﬁc
genes and on the aortic side of the valve [42]. In addition, an
Figure 4 Illustration of some of the mechanostransduction pathways activated inside VECs in response to shear stress. Cells sense shear
stress through mechanosensors on their surface which trigger activation of intracellular mediators such as nuclear factor-kB (NFkB) or
Rho, which lead to synthesis of various signaling molecules which are either directly released by the cells or translocate to the nucleus and
induce modiﬁcations in gene expression. The pathways activated result in different effects including modiﬁed chemotaxis, cell adhesion
and expression of inﬂammatory markers (adapted from [46,62]).
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in vitro study examining the role of strain on VEC activation
in vitro showed that overstretching of the cells induces the
expression of adhesion molecules, an important initial event
leading to local inﬂammation which is characterized by mono-
cyte chemotaxis and inﬁltration [54]. Physiological strain
which was evaluated as a cyclical stretch of 10% did not affect
VECs, whereas 20% cyclical strain on resulted in expression of
VCAM-1, ICAM-1 and E-selectin [54], similar to what is com-
monly observed in calciﬁed human valves. In addition, a recent
study by Kennedy et al. using an in vitro model of VIC calci-
ﬁcation such as described by us and others [55,56], demon-
strated that addition of nitric oxide donors or agents raising
intracellular cyclic guanosine monophosphate (cGMP) levels
led to a decrease in the formation of calciﬁed nodules in re-
sponse to stimulation with osteogenic medium and transform-
ing growth factor b (TGFb), an important pathogenic element
in vascular and valvular calciﬁcation [57]. Furthermore, in our
laboratory, we developed an in vitro model of aortic valve cal-
ciﬁcation by exposing whole cusp tissue to osteogenic medium
for a period of 10–14 days. Preliminary data show that similar
to what is observed in vivo, calcium nodules (characterized by
positive Alizarin-red staining) were present on the aortic side
of the valve. More importantly, endothelial denudation of
the cusp surface using a cell scraper or addition of L-NAME
(an inhibitor of nitric oxide synthase) led to a signiﬁcant in-
crease in the number of Alizarin-red positive nodules (data
not published).
Taken together, these results strongly suggest that a healthy
and functional valve endothelium acts an important ﬁrst-line
barrier against valve calciﬁcation. The endothelium appears
to exert its effect by a combination of effects on overall valve
structure and function. It can modify the mechanical proper-
ties of the cusps which might have an important effect in pro-
tecting the leaﬂets from high mechanical stresses. These
elevated stresses on the cusps can eventually lead to areas of
‘‘micro-tears’’ or interruption of the endothelial barrier. As a
consequence, the endothelium which appears to protect
against calciﬁcation by communicating with the VICs in a par-
acrine way loses this capacity and exposes the VICs to osteo-
genic stimuli. VICs have been shown to respond to direct
osteogenic stimuli by expressing a high number of activated
ﬁbroblasts, the myoﬁbroblasts. These cells have the capacity
to transdifferentiate into osteogenic-like cells and produce
hydroxyapatite.
Clinical implications
The importance of the living cellular environment in the valve
is aptly illustrated in patients requiring aortic valve replace-
ment surgery [58]. Most aortic valve prostheses are acellular,
including tissue valve prostheses and even aortic homografts
which become rapidly decellularized. These different valve sub-
stitutes are hampered by their limited durability due to struc-
tural valve deterioration [59]. However, one operation
consists of replacing the diseased aortic root with the patient’s
pulmonary root: the Ross procedure. It is the only operation
which guarantees long-term viability of the neo-aortic valve.
This in turn directly translates into a signiﬁcant beneﬁt to
the patients in terms of survival, freedom from reoperation,
freedom from valve-related complications and quality of life
[60]. We believe that this observed beneﬁt is in large part due
to the ability of the neo-aortic root to adapt to its hemody-
namic environment, to respond to various stimuli and to con-
tinuously repair in a similar fashion to normal valves [61].
Nevertheless, the Ross procedure is a technically complex
operation which results in uneven results among different
centers around the world. Therefore, a more reproducible
approach is necessary. This will be best addressed by progresses
in heart valve tissue engineering. Although some promising
ﬁrst steps were made, more is required both in understanding
normal valve physiology and combining biological, biochemi-
cal, engineering, physics and nanotechnology expertise to
develop a biocompatible tri-layered aortic valve substitute that
can reproduce the sophisticated functions of the normal aortic
valve. We and others are making big strides towards reaching
that goal and are optimistic that a fully tissue-engineered heart
valve will eventually become a viable option for patients
undergoing valve replacement surgery.
Finally, therapeutic strategies targeting the endothelium
could have a major impact on the treatment of aortic valve dis-
ease. Various agents have shown promise in reducing, revers-
ing or slowing the progression of vascular atherosclerotic
disease, including statins [55]. In addition to their lipid-lower-
ing effect, statins exhibit a range of pleiotropic effects which
can have a direct impact on endothelial function and address
the different pathological mechanisms associated with hyper-
cholesterolemia which lead to valve calciﬁcation, such as apop-
tosis [62]. Thus far, most clinical trials have shown mixed
results for the use of statins in patients with aortic valve dis-
ease. However, it is possible that statin administration needs
to be initiated as primary prevention in order to show a reduc-
tion in the incidence of aortic valve disease. In the mean time,
search for other more endothelial-speciﬁc compounds should
be undertaken and will only be possible following a thorough
understanding of the speciﬁc biology of VECs.
Conclusion
The aortic valve lies at a critical junction in the circulatory sys-
tem and is subjected to extremes of mechanical and hemody-
namic forces with every cardiac cycle. Yet, in the majority of
people, these thin structures never fail. This is a result of the
highly sophisticated cellular and molecular functions of aortic
valves. We have overviewed the contribution of the endothe-
lium to the structure and function of aortic valves in health
and disease. As our knowledge of these cells both in vitro
and in vivo increases, understanding of the pathophysiological
mechanisms of aortic valve disease will become clearer. It is
hoped that this will open opportunities towards targeted ther-
apeutic approaches to aortic valve disease, starting with tissue
engineering of heart valves.
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